Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 838 of 1,261

  1. US 8609608

    Antimicrobial peptides

    The Regents of the University of California · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  2. US 8609417

    Methods and compositions for stem cell cultures

    The Regents of the University of California · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  3. US 8609412

    Mapc generation of lung tissue

    Regents of the University of Minnesota · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  4. US 8609404

    Vaccines containing canine parvovirus genetic variants

    The Board of Regents for Oklahoma State University · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  5. US 8609395

    Agonist and antagonist peptides of carcinoembryonic antigen (CEA)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  6. US 8609162

    Integrated neuromodulation system for mood enhancement of a living human subject

    InVivo Beverages LLC · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  7. US 8609408

    Method for the reconstruction of a tissue-engineered human corneal endothelium

    OCEAN UNIVERSITY OF CHINA · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  8. US 8609334

    Biomarkers for painful intervertebral discs and methods of use thereof

    The Regents of the University of California · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  9. US 8609235

    Porous ceramic material and method of producing the same

    KURARAY CO., LTD. · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  10. US 8609706

    Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

    Infinity Discovery, Inc. · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  11. US 8609848

    Pyrazolone-derivatives and their use as PDE-4 inhibitors

    TAKEDA GMBH · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  12. US 8609843

    Photoactive metal nitrosyls for blood pressure regulation and cancer therapy

    The Regents of the University of California · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  13. US 8609838

    Pyrimidine substituted purine derivatives

    VERASTEM, INC. · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  14. US 8609856

    Crystalline forms of Febuxostat

    Teva Pharmaceuticals USA, Inc. · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  15. US 8609716

    Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  16. US 8609682

    Analgesic agents

    Regents of the University of Minnesota · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  17. US 8609703

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  18. US 8609651

    Pharmaceutical compositions of benzodiazepines and method of use thereof

    Jazz Pharmaceuticals, Inc. · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  19. US 8609607

    Modified defensins and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  20. US 8609367

    Genes and proteins for the biosynthesis of the lantibiotic 107891

    Sentinella Pharmaceuticals, Inc. · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  21. US 8604203

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  22. US 8604033

    Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  23. US 8604244

    Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  24. US 8604058

    4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance, Inc. · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.